Skip to main content
Erschienen in: Acta Neuropathologica 2/2005

01.08.2005 | Case Report

Neuronal intranuclear inclusion disease in a horse

verfasst von: M. Pumarola, E. Vidal, J. M. Trens, A. Serafín, M. Marquez, I. Ferrer

Erschienen in: Acta Neuropathologica | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Abstract

Neuronal intranuclear inclusion disease (NIID) is reported in a 16-year-old Pure Spanish breed female horse suffering from progressive ataxia and motor deficiencies. The neuropathological study revealed NIIs throughout the central nervous system, although mainly in the brain stem and spinal cord. This distribution did not correlate with neuron loss, which was marked in the hippocampus and moderate in the neocortex, particularly in the occipital cortex. As in humans, NIIs in the horse were hyaline autofluorescent inclusions composed of non-membrane-bound aggregates of filaments and fine granules. NIIs were stained with anti-ubiquitin and anti-clusterin antibodies. In addition, NIIs were stained with antibodies raised against subunits of the 19S and PA28, but not of the 20S, components of the proteasome. These observations indicate similarities between NIID in humans and horses, and suggest that clusterin and abnormal ubiquitin-proteasomal expression participate in NII formation.
Literatur
1.
Zurück zum Zitat Bugiani O, Giaccone G, Frigerio L, Farlow MR, Ghetti B, Tagliavini F (1994) Apolipoprotein E and J in immunoreactivity in Gerstmann-Straüssler-Scheinker disease. Neurobiol Aging 15:S156–S157 Bugiani O, Giaccone G, Frigerio L, Farlow MR, Ghetti B, Tagliavini F (1994) Apolipoprotein E and J in immunoreactivity in Gerstmann-Straüssler-Scheinker disease. Neurobiol Aging 15:S156–S157
2.
Zurück zum Zitat Ferrer I, Carmona M, Blanco R, Moreno D, Torrejón-Escribano B, Olivé M (2005) Involvement of clusterin and the aggresome in abnormal protein deposition in myofibrillar myopathies and inclusion body myositis. Brain Pathol 15:101–108PubMed Ferrer I, Carmona M, Blanco R, Moreno D, Torrejón-Escribano B, Olivé M (2005) Involvement of clusterin and the aggresome in abnormal protein deposition in myofibrillar myopathies and inclusion body myositis. Brain Pathol 15:101–108PubMed
3.
Zurück zum Zitat Freixes M, Puig B, Rodriguez A, Torrejón-Escribano B, Blanco R, Ferrer I (2004) Clusterin solubility and aggregation in Creutzfeldt-Jakob disease. Acta Neuropathol 108:295–301 Freixes M, Puig B, Rodriguez A, Torrejón-Escribano B, Blanco R, Ferrer I (2004) Clusterin solubility and aggregation in Creutzfeldt-Jakob disease. Acta Neuropathol 108:295–301
4.
Zurück zum Zitat Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev 82:373–428PubMed Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev 82:373–428PubMed
5.
Zurück zum Zitat Jones SE, Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34:427–431PubMed Jones SE, Jomary C (2002) Clusterin. Int J Biochem Cell Biol 34:427–431PubMed
6.
Zurück zum Zitat Haltia M (2003) Neuronal intranuclear inclusion disease. In: Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 404–406 Haltia M (2003) Neuronal intranuclear inclusion disease. In: Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropath Press, Basel, pp 404–406
7.
Zurück zum Zitat Kulikova-Schupak R, Knupp KG, Pascual JM, Chin SS, Kairam R, Patterson MC (2004) Rectal biopsy in the diagnosis of neuronal intranuclear hyaline inclusion disease. J Child Neurol 19:59–62PubMed Kulikova-Schupak R, Knupp KG, Pascual JM, Chin SS, Kairam R, Patterson MC (2004) Rectal biopsy in the diagnosis of neuronal intranuclear hyaline inclusion disease. J Child Neurol 19:59–62PubMed
8.
Zurück zum Zitat Lieberman AP, Robitaille Y, Trojanowski JQ, Dickson DW, Fischbeck KH (1998) Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease. Lancet 351:884CrossRefPubMed Lieberman AP, Robitaille Y, Trojanowski JQ, Dickson DW, Fischbeck KH (1998) Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease. Lancet 351:884CrossRefPubMed
9.
Zurück zum Zitat Lieberman AP, Trojanowski JQ, Leonard DG, Chen K, Barnett J, Leverenz J, Bird T, Robitaille Y, Malandrini A, Fischbeck K (1999) Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease. Ann Neurol 46:271–273CrossRefPubMed Lieberman AP, Trojanowski JQ, Leonard DG, Chen K, Barnett J, Leverenz J, Bird T, Robitaille Y, Malandrini A, Fischbeck K (1999) Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease. Ann Neurol 46:271–273CrossRefPubMed
10.
Zurück zum Zitat McGeer PL, Kawamata T, Walker DG (1992) Distribution of clusterin in Alzheimer brain tissue. Brain Res 579:337–341CrossRefPubMed McGeer PL, Kawamata T, Walker DG (1992) Distribution of clusterin in Alzheimer brain tissue. Brain Res 579:337–341CrossRefPubMed
11.
Zurück zum Zitat O’Sullivan JD, Hanagasi HA, Daniel SE, Tidswell P, Davies SW, Lees AJ (2000) Neuronal intranuclear inclusion disease and juvenile parkinsonism. Mov Disord 15:990–995CrossRefPubMed O’Sullivan JD, Hanagasi HA, Daniel SE, Tidswell P, Davies SW, Lees AJ (2000) Neuronal intranuclear inclusion disease and juvenile parkinsonism. Mov Disord 15:990–995CrossRefPubMed
12.
Zurück zum Zitat Rosenberg ME, Silkensen J (1995) Clusterin: physiological and pathological considerations. Int Biochem Cell Biol 27:633–645CrossRef Rosenberg ME, Silkensen J (1995) Clusterin: physiological and pathological considerations. Int Biochem Cell Biol 27:633–645CrossRef
13.
Zurück zum Zitat Sasaki K, Doh-ura K, Ironside JW, Iwaki T (2002) Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies. Acta Neuropathol 103:199–208 Sasaki K, Doh-ura K, Ironside JW, Iwaki T (2002) Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies. Acta Neuropathol 103:199–208
14.
Zurück zum Zitat Sasaki K, Doh-ura K, Wakisawa Y, Iwaki T (2002) Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with α-synucleinopathies. Acta Neuropathol 104:225–230 Sasaki K, Doh-ura K, Wakisawa Y, Iwaki T (2002) Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with α-synucleinopathies. Acta Neuropathol 104:225–230
15.
Zurück zum Zitat Schmidt T, Lindenberg K, Krebs A, Schöls L, Lacone F, Herms J, Rechsteiner M, Riess O, Landwehrmeyer G (2002) Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann Neurol 51:302–310CrossRefPubMed Schmidt T, Lindenberg K, Krebs A, Schöls L, Lacone F, Herms J, Rechsteiner M, Riess O, Landwehrmeyer G (2002) Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann Neurol 51:302–310CrossRefPubMed
16.
Zurück zum Zitat Seilhean D, Takahashi J, El Hachimi KH, Fujigasaki H, Lebre AS, Biancalana V, Durr A, Salachas F, Hogenhuis J, The H de, Hauw JJ, Meininger V, Brice A, Duyckaerts C (2004) Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions. Acta Neuropathol 108:81–87 Seilhean D, Takahashi J, El Hachimi KH, Fujigasaki H, Lebre AS, Biancalana V, Durr A, Salachas F, Hogenhuis J, The H de, Hauw JJ, Meininger V, Brice A, Duyckaerts C (2004) Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions. Acta Neuropathol 108:81–87
17.
Zurück zum Zitat Sloane AE, Becker LE, Ang LC, Wark J, Haslam RH (1994) Neuronal intranuclear hyaline inclusion disease with progressive cerebellar ataxia. Pediatr Neurol 10:61–66CrossRefPubMed Sloane AE, Becker LE, Ang LC, Wark J, Haslam RH (1994) Neuronal intranuclear hyaline inclusion disease with progressive cerebellar ataxia. Pediatr Neurol 10:61–66CrossRefPubMed
18.
Zurück zum Zitat Takahashi J, Fukuda T, Tanaka J, Minamitani M, Fujigasaki H, Uchihara T (2000) Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions. Acta Neuropathol 99:589–594 Takahashi J, Fukuda T, Tanaka J, Minamitani M, Fujigasaki H, Uchihara T (2000) Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions. Acta Neuropathol 99:589–594
19.
Zurück zum Zitat Takahashi J, Tanaka J, Arai K, Funata N, Hattori T, Fukuda T, Fujigasaki H, Uchihara T (2001) Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J Neuropathol Exp Neurol 60:369–376PubMed Takahashi J, Tanaka J, Arai K, Funata N, Hattori T, Fukuda T, Fujigasaki H, Uchihara T (2001) Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J Neuropathol Exp Neurol 60:369–376PubMed
20.
Zurück zum Zitat Takahashi-Fujigasaki J (2003) Neuronal intranuclear hyaline inclusion disease. Neuropathology 23:351–359CrossRefPubMed Takahashi-Fujigasaki J (2003) Neuronal intranuclear hyaline inclusion disease. Neuropathology 23:351–359CrossRefPubMed
21.
Zurück zum Zitat Uchihara T, Tanaka J, Funata N, Arai K, Hattori T (2003) Influences of intranuclear inclusion on nuclear size—morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases. Acta Neuropathol 105:103–108 Uchihara T, Tanaka J, Funata N, Arai K, Hattori T (2003) Influences of intranuclear inclusion on nuclear size—morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases. Acta Neuropathol 105:103–108
Metadaten
Titel
Neuronal intranuclear inclusion disease in a horse
verfasst von
M. Pumarola
E. Vidal
J. M. Trens
A. Serafín
M. Marquez
I. Ferrer
Publikationsdatum
01.08.2005
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 2/2005
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-005-1033-5

Weitere Artikel der Ausgabe 2/2005

Acta Neuropathologica 2/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.